We provide a collaborative team approach to the management of approximately 350 new patients with leukemia annually. A primary doctor closely coordinates the care of hematologists, medical and radiation oncologists, bone marrow and stem cell specialists, pathologists, and others. The team meets weekly to discuss and update each patient’s treatment plan. Our many clinical trials incorporate innovative therapies for various types of leukemias. We are recognized as leaders in immunotherapy and the development of novel drug strategies for a number of leukemias.
E-Publications for Medical Professionals
Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.